ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Agilent Technologies Inc

Agilent Technologies Inc (A1GI34)

442.66
0.00
(0.00%)
Closed 03 February 7:55AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
442.66
Bid
0.00
Offer
0.00
Volume
-
0.00 Day's Range 0.00
328.40 52 Week Range 442.66
Market Cap
Previous Close
442.66
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
16
Shares Outstanding
287,328,000
Dividend Yield
0.45%
PE Ratio
33.77
Earnings Per Share (EPS)
4.49
Revenue
6.51B
Net Profit
1.29B

About Agilent Technologies Inc

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Agilent Technologies Inc is listed in the Lab Analytical Instruments sector of the Brazil Bovespa Exchange with ticker A1GI34. The last closing price for Agilent Technologies was R$442.66. Over the last year, Agilent Technologies shares have traded in a share price range of R$ 328.40 to R$ 442.66.

Agilent Technologies currently has 287,328,000 shares in issue. The market capitalisation of Agilent Technologies is R$127.19 billion. Agilent Technologies has a price to earnings ratio (PE ratio) of 33.77.

A1GI34 Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
100442.66442.66442.6633442.66DR
411.652.70295352776431.01442.66431.0139437.14DR
1239.799.87663514285402.87442.66402.8716430.19017699DR
2671.3119.2029083075371.35442.66371.2615405.87133929DR
52113.6534.5430230084329.01442.66328.411396.92498113DR
15674.7320.3109287093367.93442.66275.2437335.15175947DR
260256.44137.708087209186.22476.29186.22188413.15330044DR

A1GI34 - Frequently Asked Questions (FAQ)

What is the current Agilent Technologies share price?
The current share price of Agilent Technologies is R$ 442.66
How many Agilent Technologies shares are in issue?
Agilent Technologies has 287,328,000 shares in issue
What is the market cap of Agilent Technologies?
The market capitalisation of Agilent Technologies is BRL 127.19B
What is the 1 year trading range for Agilent Technologies share price?
Agilent Technologies has traded in the range of R$ 328.40 to R$ 442.66 during the past year
What is the PE ratio of Agilent Technologies?
The price to earnings ratio of Agilent Technologies is 33.77
What is the cash to sales ratio of Agilent Technologies?
The cash to sales ratio of Agilent Technologies is 6.69
What is the reporting currency for Agilent Technologies?
Agilent Technologies reports financial results in USD
What is the latest annual turnover for Agilent Technologies?
The latest annual turnover of Agilent Technologies is USD 6.51B
What is the latest annual profit for Agilent Technologies?
The latest annual profit of Agilent Technologies is USD 1.29B
What is the registered address of Agilent Technologies?
The registered address for Agilent Technologies is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Agilent Technologies website address?
The website address for Agilent Technologies is www.agilent.com
Which industry sector does Agilent Technologies operate in?
Agilent Technologies operates in the LAB ANALYTICAL INSTRUMENTS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PGMN11Empreendimentos Pague Menos S.A.
R$ 0.49
(40.00%)
2.7k
CTKA3Karsten Sa ex Cia Textil Karsten
R$ 24.50
(14.22%)
300
AZEV4Azevedo Travassos Sa
R$ 1.30
(12.07%)
10.66M
TELB3Telec Brasileiras-Telebras
R$ 13.20
(10.46%)
1.1k
PEAB4Cia Participacoes Alianca Bahia
R$ 51.98
(9.43%)
1,000
IFCM3Infracommerce Caxaas S.A.
R$ 0.07
(-12.50%)
4.69M
NGRD3Neogrid Participacoes SA
R$ 20.33
(-6.66%)
52.7k
LPSB3Lps Brasil Consultoria Imoveis Sa
R$ 1.30
(-5.80%)
199.8k
ZAMP3Zamp S.A.
R$ 2.91
(-5.21%)
450.2k
VBBR3Vibra Energia S.A.
R$ 16.86
(-5.07%)
22.37M
AMOB3Automob Participacoes Sa
R$ 0.31
(0.00%)
55.98M
HAPV3Hapvida Participacoes Investimento SA
R$ 2.42
(-1.22%)
55.62M
COGN3CognaEducacao SA
R$ 1.41
(1.44%)
39.92M
BBDC4Bco Bradesco Sa
R$ 12.09
(-0.411862%)
37.53M
PETR4Petroleo Brasileiro S.A. Petrobras
R$ 37.69
(0.802354%)
37.04M

Discussion

View Full Feed
benhor benhor 3 minutes ago
$STSS GET YOUR CHEAP SHARES BEFORE THE EXPLOSION STARTS THIS WEEK
STSS
Vexari Vexari 3 minutes ago
It's a nice change of pace

Regardless
xoom xoom 3 minutes ago
I think RD posts about all potential deals happening at that instant on this planet. There will be a day, when one of the deals he posts about, is our actual deal. On that day RD will point a finger at you and say ‘ I told you so ‘
COOP
benhor benhor 3 minutes ago
$STSS GET YOUR CHEAP SHARES BEFORE THE EXPLOSION STARTS THIS WEEK
STSS
delerious1 delerious1 4 minutes ago
We all know that this week and/or next could be a blast for NBRI and us😎.....gonna be some fun this month
NBRI
benhor benhor 4 minutes ago
$STSS GET YOUR CHEAP SHARES BEFORE THE EXPLOSION STARTS THIS WEEK
STSS
Vexari Vexari 6 minutes ago
Awfully quiet
BOREALIS BOREALIS 6 minutes ago
Trump kept his pledge on tariffs. Is he ready for the fallout? Are Americans?
Here’s what to know

By BILL BARROW
Updated 6:22 PM CST, February 2, 2025

ATLANTA (AP) — President Donald Trump has taken executive action to impose new tariffs on imports from
gfp927z gfp927z 7 minutes ago
Rickards praises Trump, then says we'll soon have a stock market crash and recession (?) He loves the executive orders ('rule by decree'), and loves the tariffs, even if the resulting inflation and high % rates will accelerate the debt bomb and crash the markets. Rickards doesn't even mention Trum
Elroy Jetson Elroy Jetson 8 minutes ago
Trump is a buffoon acting like a king - because he is too weak to govern like a president.

https://www.nytimes.com/2025/02/02/opinion/ezra-klein-podcast-trump-column-read.html?unlocked_article_code=1.t04.v61j.h_eaTdRj3_sz&smid=url-share
blackhawks blackhawks 8 minutes ago
What ARE the privacy issues with Google? I've been using it without privacy consequences since I discovered it in my workplace in late1998.

Cost/benefits, to me. None imposed, plenty realized.

Want to still be using Yahoo, Alta Vista, Lycos, Ask Jeeves, Infoseek?
janice shell janice shell 9 minutes ago
You are no doubt exactly right.
Dallas-Cowboys Dallas-Cowboys 9 minutes ago
The electronic Trojan Horse 
NVDA
Monroe1 Monroe1 9 minutes ago
dims are the dimest of all, the lowest common denominator. Put this in your pipe and smoke it.
And don't hesitate to get in that jab line. Now who would ever take their kids to get these jabs?
Well, I will tell you. The same dims who don't do real research but swallow the garbage emi
Almosthere Almosthere 9 minutes ago
Tomcat, I think we will see a run. It’s been three years. Fingers crossed.
LQMT
bigtalan bigtalan 9 minutes ago
I would say that we probably wont hear much from Jeff until after this second Conference. GLTA
RSPI
Bill48 Bill48 10 minutes ago
If you feel like that!! Can you explain what kind of basher/ disrupter you’re talking about ! Thanks
COOP
Real McCoy Real McCoy 11 minutes ago
Bioamber doesn’t have any technology though. It was all sold off in the liquidation.
KRISGO KRISGO 11 minutes ago
The key is moving the share price up—otherwise, these endless debates about what might happen in the future are pointless. Every time we get excited about some big news or momentum after hearing something on a Friday, Monday rolls around and nothing happens, leaving us disappointed. But this time, w
NWBO
pinhigh pinhigh 11 minutes ago
Good point IB.....Actipatch is all about the percentage of people it helps....not the random case.
BIEL
Vexari Vexari 12 minutes ago
Where is everyone?

Not too late

Just roll

Dice

Practice

Makes perfect
janice shell janice shell 13 minutes ago
Good point!
tnyellowtomcat tnyellowtomcat 13 minutes ago
Chip,

Ask TC when we will ALL be rich!

Thanks - Tomcat
LQMT
janice shell janice shell 13 minutes ago
Oh, I think you could be right about that. And the cost can also be appalling. We do on average take lots more drugs than people elsewhere. And then there're the possible side effects.
Big Benny Big Benny 14 minutes ago
Maybe I am too enthusiastic. But if they have a product that can make stem cells be created more quickly in the human body, I can't help but think that the possibilities are enormous.

BB
BDPT

Your Recent History

Delayed Upgrade Clock